Home / Intelligence / Analyst Reports / Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences
Everest Group report:
AI-deas to Action: Operationalizing Generative AI in Life Sciences
This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included.
The report highlights several of Trinity’s key strengths, including:
Life Sciences Industry Expertise
Trinity has nearly 30 years of experience in the industry, providing evidence-based solutions to over 300 clients, including the global top 20 biopharma companies. This deep expertise translates siloed information into meaningful and effective insights.
Collaboration Between AI Technology and Human Experts
By embedding expert-driven feedback loops, Trinity enhances the accuracy and relevance of AI outputs, creating a collaborative environment where AI technology and human insights work together to drive efficiency, innovation and strategic decision‑making.
GenAI Tailored for the Life Sciences
The Trinity approach integrates cutting-edge GenAI models with domain-specific data to optimize GenAI for specific life sciences functions.
Access the report
We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Trinity Life Sciences’ generative AI strategy blends foundational AI models with deep life sciences expertise, focusing on high-quality data, targeted functional optimization, and an expert-driven feedback loop. Through a value chain segment-based approach, particularly rooted in the sales and marketing segment, the company is working to drive meaningful AI adoption.
—Aastha Malik, Practice Director at Everest Group
Related Intelligence
Blog
Operationalizing Generative AI in Life Sciences—Trinity Life Sciences Included in Everest Group Report
The transformative potential of generative AI (GenAI) within the life sciences industry is highlighted in Everest Group’s report, “AI-deas to Action: Operationalizing Generative AI in Life Sciences.” Fifteen companies were selected for inclusion across three categories: To be included in the report, providers had to have been profiled in past Everest Group PEAK Matrix® […]
Read More
Webinars
Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]
Watch Now
Webinars
The Future of Patient Finding
Available On Demand
Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient finding is evolving. Many pharma organizations have deep-rooted ideas about what patient finding requires, but they often miss the opportunity to put the patient at […]
Watch Now